Summary
Differentials
Common
- Allergy to food or drug
- Insect bites or stings
- Adverse drug reaction (e.g., to antibiotic, anticonvulsant, or allopurinol)
- Chemotherapy
- Enterovirus and echovirus infection
- Fifth disease (erythema infectiosum)
- Roseola infantum (sixth disease)
- Epstein Barr virus (EBV) infection (infectious mononucleosis)
- Cytomegalovirus (CMV) infection
Uncommon
- Iodinated contrast media nonimmediate adverse reaction
- Toxic epidermal necrolysis/Stevens-Johnson syndrome
- Drug reaction with eosinophilia and systemic symptoms
- Erythema multiforme
- HIV-seroconversion exanthema (also known as acute retroviral syndrome)
- Mpox
- Sepsis
- Acute hepatitis B virus infection
- Acute hepatitis C virus infection
- Rubella (German measles)
- Rubeola (measles)
- Meningococcemia
- Scarlet fever
- Staphylococcal scalded skin syndrome
- Toxic shock syndrome (Staphylococcus exotoxin)
- Rocky Mountain spotted fever or Mediterranean spotted fever
- Acute graft-versus-host disease
- Kawasaki disease (mucocutaneous lymph node syndrome)
- Juvenile-onset or adult-onset Still disease
- Syphilis (secondary)
- Ebola disease
- Zika virus infection
- Chikungunya virus infection
- Dengue fever
Colaboradores
Autores
Adelaide A. Hebert, MD
Professor & Director of Pediatric Dermatology
Department of Dermatology and Pediatrics
UTHealth McGovern Medical School Houston
Houston
TX
Declarações
AAH has received research grants paid to UTHealth McGovern Medical School Houston from Pfizer, GlaxoSmithKline (GSK), Novan, Dermavant, Arcutis, and Verrica; has received honoraria from Pfizer, Verrica, and Novan; and is on data safety monitoring boards for GSK, Ortho Dermatologics, and Regeneron-Sanofi.
Yamila Goenaga, MD
Dermatology Resident
Department of Dermatology
University of Texas Health Sciences Center in Houston
Houston
TX
Declarações
YG declares that she has no competing interests.
Alexander J. Jafari, MD, MPH
Clinical Research Fellow
Department of Dermatology
UTHealth McGovern Medical School Houston
Houston
TX
Declarações
AJJ declares that he has no competing interests.
Agradecimentos
Dr Adelaide A. Hebert, Dr Yamila Goenaga, and Dr. Alexander Jafari would like to gratefully acknowledge Dr Quoc-Bao Nguyen, Dr Mary DarConte, Dr Mark Naftanel, and Dr Hobart W. Walling, previous contributors to this topic.
Declarações
QN, MD, MN, and HWW declare that they have no competing interests.
Revisores
Brian Swick, MD
Clinical Assistant Professor
University of Iowa College of Medicine
Iowa City
IA
Declarações
BS declares that he has no competing interests.
Kimberly Schulz, MD
Dermatologist
Town Square Dermatology
Coralville
IA
Declarações
KS declares that she has no competing interests.
Créditos aos pareceristas
Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.
Declarações
As afiliações e declarações dos pareceristas referem--se ao momento da revisão.
Referências
Principais artigos
Resuscitation Council UK. Emergency treatment of anaphylactic reactions: guidelines for healthcare providers. May 2021 [internet publication].Texto completo
Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology, et al. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010 Oct;105(4):259-73. Resumo
McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017 Apr 25;135(17):e927-99.Texto completo Resumo
Khan DA, Banerji A, Blumenthal KG, et al. Drug allergy: a 2022 practice parameter update. J Allergy Clin Immunol. 2022 Dec;150(6):1333-93.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.

Folhetos informativos para os pacientes
Hepatitis B: should I have the vaccine?
Hepatitis C: what is it?
Mais Folhetos informativos para os pacientesVideos
Venepuncture and phlebotomy: animated demonstration
Mais vídeosConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal